In the face of mounting criticism over insulin prices, Novo Nordisk (NVO) is mimicking its rivals by launching two programs that are designed to mitigate rising costs for patients.
The two-pronged effort involves a $99 cash card that can be used by anyone — regardless of whether they have insurance coverage — for a month’s supply and the introduction of authorized generic versions of two different insulin products at half the list price. These will be identical to the Novolog and Novolog Mix brand-name treatments and will be made at the same facility, but will carry modified labeling.
Continue to STAT Plus to read the full story…
Anupam Ghose, a physician by training, was diagnosed with Type 2 Diabetes Mellitus (T2DM) in 2017. After the diagnosis of T2DM, he followed a low carbohydrate high fat diet and reversed his T2DM within a year. Now he has one main goal in life and that is to make people understand that the conventional method of treating T2DM is not beneficial. Type 2 diabetes is reversible and the best way to reverse T2DM is through diet and lifestyle modifications. He now decided to help people with type 2 diabetes by offering online coaching to reverse their diabetes.